Log In

 

All News


Sort By News Date & Time Sort Descending Order News Source News Title

  Refine Search  
Keywords
Date Range
 
News Type
  India
  International

26/09/2018 2:48PM

Global survey reveals that physicians need more information to assess the impact of treatment sequencing on patient survival in EGFR mutation-positive NSCLC

Results from a new global survey revealed that more than one-third (36%) of the 310 physicians surveyed do not think they have sufficient information required to make informed decisions on how to sequence treatments for ...

17/09/2018 9:00AM

New study results provide evidence that Ofev® (nintedanib) slows progression of IPF beyond four years with consistent safety

INPULSIS®-ON study indicates safety and efficacy of Ofev® (nintedanib) are maintained over the long term and consistent with prior findings from INPULSIS® trials1 Results from INPULSIS®-ON, the ...

17/09/2018 9:15AM

Clinical trial data for nintedanib in patients with advanced IPF published

INSTAGE® trial results published in the New England Journal of Medicine1 Trial provides clinical data on patients with IPF and severe impairment in gas exchange usually excluded from clinical trials1 Efficacy ...

13/09/2018 2:28PM

Boehringer Ingelheim Acquires All ViraTherapeutics Shares to Develop Next Generation Viral-Based Immuno-Oncology Therapies

Boehringer Ingelheim exercises its option to acquire all shares of oncolytic virus company ViraTherapeutics ViraTherapeutics will operate in Innsbruck, Austria as a distinct unit of Boehringer ...

17/09/2018 1:19PM

Large European real-world study reports effects of Spiolto® Respimat® for people living with COPD in daily clinical practice1

OTIVACTO study reported improvements in both physical functioning and general condition in people living with COPD receiving Spiolto® (tiotropium/olodaterol) Respimat® therapy1 4 out of 5 ...

02/08/2018 4:50PM

Boehringer Ingelheim launches the initiative In Reach Africa to address key healthcare infrastructure and access priorities across Africa

‘In Reach Africa’ to facilitate quality and innovative human and animal healthcare access across the continent Series of activities and workshops already started Initiative underlines the ...

06/08/2018 2:43PM

Boehringer Ingelheim, the UK Cystic Fibrosis Gene Therapy Consortium, Imperial Innovations and Oxford Biomedica Announce New Partnership to Develop First-in-Class Gene Therapy for Cystic Fibrosis

This new collaboration unites leaders in cystic fibrosis gene therapy, lentiviral development and production, and the treatment of respiratory diseases to develop the first gene therapy for cystic ...

20/08/2018 5:51PM

Boehringer Ingelheim: New sub-analyses to be presented at ESC Congress 2018 further support positive safety profile of Pradaxa® (dabigatran etexilate)

Nine sub-analyses from RE-DUAL PCI™ and GLORIA™-AF accepted for presentation at ESC Congress 2018; Data from both studies have led to positive update of the SmPC for Pradaxa® in the ...